TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
RANI

Rani Therapeutics Holdings Inc

Healthcare · Biotechnology

0.749$ -2.3% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement RANI
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% – – 100.0% 100.0%
– – – – – – 55.1%
100.0% 100.0% 100.0% – – 100.0% 44.9%
2,510.6% 2,606.9% 974.7% – – 2,595.5% 1,237.3%
353.9% 1,074.0% 1,024.4% – – 2,329.4% 1,208.7%
2,864.6% 3,681.0% 1,999.1% – – 5,286.2% 2,390.9%
-2,764.6% -3,581.0% -1,899.1% – – -5,186.2% -2,346.0%
1.0% 26.8% 17.2% – – 489.6% 177.0%
-2,715.7% -3,607.8% -1,952.4% – – -2,920.0% -2,507.7%
1.0% 7.6% 1.5% – – 2,584.2% –
-2,716.8% -3,615.4% -306.6% – – -2,920.0% -1,817.1%
-2,657.1% -3,453.5% -1,917.0% – – -4,914.7% -2,275.5%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?